MedPath

Spectral CT Clinical Trial Protocol

Not Applicable
Terminated
Conditions
CT Scanning
Interventions
Device: Spectral CT
Registration Number
NCT05017233
Lead Sponsor
Philips (China) Investment CO., LTD
Brief Summary

The purpose of this study was to evaluate the expected effectiveness, ease of operation, stability, and safety of Spectral CT

Detailed Description

Under the premise of protecting subjects and ensuring the scientific nature of this study, Spectral CT was evaluated for its effectiveness, convenience, stability and safety under normal conditions by collecting clinical cases.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
51
Inclusion Criteria
  • Recruit volunteers (ages 18 to 75);
  • Negative pregnancy tests in women of childbearing age;
  • Participants who agree to participate in this clinical trial and sign the informed consent;
  • Enhanced scans require laboratory tests to confirm normal renal function.
Exclusion Criteria
  • Persons who do not have full capacity for civil conduct;
  • Lactating women;
  • People who are not suitable for enhanced scanning with iodine contrast agent;
  • Patients whom the investigator considers inappropriate to participate in this clinical trial.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Experimental group, all volunteer will be scanned.Spectral CTAll participation accept Spectral CT scanning; No group;
Primary Outcome Measures
NameTimeMethod
Excellent and good rate of clinical imaging (score≥3)through study completion, an average of 1 year

Rated items 5 points Excellent image quality for diagnostic purposes, very satisfactory 4 points good image quality, can be used for diagnosis, satisfactory 3 points Image quality defects, do not affect the diagnosis, general 2. Unsatisfactory image quality, affecting diagnosis Poor image quality, undiagnosable, unsatisfactory

Secondary Outcome Measures
NameTimeMethod
Common functions assessmentthrough study completion, an average of 1 year

Common function evaluation items inclduing:The exposure function; Bed body moving; Microphone intercom function; Image post-processing function; Data storage management. With Satisfied, normal, Not Satisfied

Convenience evaluation assessmentthrough study completion, an average of 1 year

Convenience function evaluation items inclduing:Laser positioning lamp Breathing navigation Control buttons The clinical interface friendliness of postprocessing software The post-processing software is convenient for clinical use and operation. With Satisfied, normal, Not Satisfied

Machine function and stability assessmentthrough study completion, an average of 1 year

Machine function and stability evaluation items inclduing:workflow Image display and transmission Failed to start system Unexpected system shutdown Abnormal termination during the scan Unable to expose during scan. With Satisfied, normal, Not Satisfied

Adverse events and serious adverse eventsthrough study completion, an average of 1 year

Adverse events and serious adverse events during the test were collected to evaluate the safety of the product.

Trial Locations

Locations (3)

West China Hospital

🇨🇳

Chengdu, Sichuan, China

Ruijin Hospital

🇨🇳

Shanghai, China

Shanghai Changzheng Hospital

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath